NexLife Compounded Tirzepatide Injection

Close-up illustration of a compounded tirzepatide injection vial labeled 20 mg/mL and 3 mL against a white background.

Illustrative image of compounded tirzepatide injection offered through NexLife’s physician-led telehealth program. NexLife provides flat-rate pricing that remains the same across provider-prescribed doses. Compounded tirzepatide is not FDA-approved.

Format

PNG

Source

Nexlife

Downloads